Figure 2From: Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy After-recurrence survival (ARS) in the SR and in the NSR group. The survival is significantly increased in the SR group compared to the NSR group (p < 0.001).Back to article page